EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

KIFC1 is Associated With Sarcomatoid Differentiation, Immune Response, and a Poor Prognosis in Clear Cell Renal Cell Carcinoma

Yoshinori Nakano iD, Yohei Sekino iD, Go Kobayashi, Hikaru Nakahara, Shintaro Akabane, Kenshiro Takemoto iD, Miki Naito iD, Shunsuke Miyamoto iD, Kohei Kobatake iD, Hiroyuki Kitano iD, Keisuke Goto, Akihiro Goriki und 3 weitere

Cancer Medicine · 2026

DOI: 10.1002/cam4.71687 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Medicine, 2026. Verfasst von Yoshinori Nakano und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, Kinesins, Kidney Neoplasms, Biomarkers, Tumor. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Centrosome clustering is a cancer‐specific adaptation that allows cells with centrosome amplification to evade mitotic catastrophe and has emerged as a potential therapeutic target. We analyzed the prognostic role of several molecules related to centrosome clustering and found that Kinesin Family Member C1 ( KIFC1 ) was strongly associated with a poor prognosis. KIFC1, a kinesin motor protein, plays a central role in centrosome clustering. However, its biological and clinical significance in clear cell renal cell carcinoma (ccRCC) remains poorly understood.

Methods

We conducted a comprehensive analysis using several public datasets (TCGA KIRC, JAVELIN101, IMmotion151, and others) and a Hiroshima ccRCC cohort ( n = 110) to evaluate the expression of KIFC1 , clinicopathological associations, the prognosis, and treatment response. Gene Set Enrichment Analysis was performed to explore associated pathways.

Results

Immunohistochemical and in silico analyses showed that high KIFC1 expression was significantly associated with high tumor grade, advanced TNM stage, and sarcomatoid differentiation. A multivariate analysis demonstrated that the high‐expression of KIFC1 was independently associated with poor overall survival. Gene Set Enrichment Analysis revealed enrichment of epithelial–mesenchymal transition and interferon gamma response pathways in KIFC1 ‐high tumors. The expression of KIFC1 was also correlated with TKI resistance, immune response, high clonal neoantigen load, and BAP1 mutation.

Conclusion

KIFC1 serves as a multifunctional molecule linking epithelial–mesenchymal transition, immune modulation, and treatment resistance. It may be a promising prognostic biomarker and therapeutic target in ccRCC, warranting further functional and clinical investigation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Renal CellKinesinsKidney NeoplasmsBiomarkers, TumorHumansPrognosisFemaleMaleEpithelial-Mesenchymal TransitionCell DifferentiationMiddle AgedGene Expression Regulation, Neoplastic

Stichwörter der Autor:innen

KIFC1centrosome clusteringepithelial–mesenchymal transitionimmune responserenal cell carcinoma

Substanzen

KinesinsKIFC1 protein, humanBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Urology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
  • Laboratory of Molecular Pathology, Department of Molecular Biosciences, Radiation Effects Research Foundation, Hiroshima, Japan.
  • Department of Clinical and Molecular Genetics, Hiroshima University Hospital, Hiroshima, Japan.
  • Department of Gastroenterological and Transplant Surgery, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.

ORCID-Profile: Yoshinori Nakano, Yohei Sekino, Kenshiro Takemoto, Miki Naito, Shunsuke Miyamoto, Kohei Kobatake, Hiroyuki Kitano, Nobuyuki Hinata

Förderung

  • Japan Society for the Promotion of Science

Zitieren

APA

Nakano, Y., Sekino, Y., Kobayashi, G., Nakahara, H., Akabane, S., Takemoto, K., Naito, M., Miyamoto, S., Kobatake, K., Kitano, H., Goto, K., Goriki, A., Hieda, K., Hinoi, T., & Hinata, N. (2026). KIFC1 is Associated With Sarcomatoid Differentiation, Immune Response, and a Poor Prognosis in Clear Cell Renal Cell Carcinoma. Cancer Medicine. https://doi.org/10.1002/cam4.71687

Vancouver

Nakano Y, Sekino Y, Kobayashi G, Nakahara H, Akabane S, Takemoto K, et al. KIFC1 is Associated With Sarcomatoid Differentiation, Immune Response, and a Poor Prognosis in Clear Cell Renal Cell Carcinoma. Cancer Medicine. 2026. doi:10.1002/cam4.71687

BibTeX
@article{Nakano2026,
  author = {Nakano, Yoshinori and Sekino, Yohei and Kobayashi, Go and Nakahara, Hikaru and Akabane, Shintaro and Takemoto, Kenshiro and Naito, Miki and Miyamoto, Shunsuke and Kobatake, Kohei and Kitano, Hiroyuki and Goto, Keisuke and Goriki, Akihiro and Hieda, Keisuke and Hinoi, Takao and Hinata, Nobuyuki},
  title = {KIFC1 is Associated With Sarcomatoid Differentiation, Immune Response, and a Poor Prognosis in Clear Cell Renal Cell Carcinoma},
  journal = {Cancer Medicine},
  year = {2026},
  doi = {10.1002/cam4.71687}
}
Kostenlos starten →